These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 5466703

  • 21. Study of pituitary hormone analogs for their inhibitory properties and resistance to carboxamidopeptidases: (9-L-proline)oxytocin, (9-L-glutamic acid)oxytocin, and (8-L-lysine,9-glycine methylamide)oxytocin.
    Grzonka Z, Glass JD, Schwartz IL, Walter R.
    J Med Chem; 1974 Dec; 17(12):1294-8. PubMed ID: 4427327
    [No Abstract] [Full Text] [Related]

  • 22. Further studies of the role of the asparagine residue in oxytocin. Synthesis and biological properties of (5- , -diaminobutyric acid)oxytocin.
    Hase S, Schwartz IL, Walter R.
    J Med Chem; 1972 Feb; 15(2):126-8. PubMed ID: 5008236
    [No Abstract] [Full Text] [Related]

  • 23. N-acetyl-2-O-methyl-tyrosine-oxytocin: a specific antagonist of oxytocin.
    Krejcí I, Kupková B, Barth T, Jost K.
    Physiol Bohemoslov; 1973 Feb; 22(3):315-22. PubMed ID: 4359811
    [No Abstract] [Full Text] [Related]

  • 24. [Uterine contractility. On the response of the uterus to oxytocin].
    Nomura Y.
    Nihon Ika Daigaku Zasshi; 1971 Apr; 38(2):77-85. PubMed ID: 5558466
    [No Abstract] [Full Text] [Related]

  • 25. Synthesis and some pharmacological properties of [4-threonine,7-sarcosine]oxytocin, a peptide with high oxytocic potency, and of [4-threonine,7-N-methylalanine]oxytocin.
    Grzonka Z, Lammek B, Gazis D, Schwartz IL.
    J Med Chem; 1983 Dec; 26(12):1786-7. PubMed ID: 6685771
    [Abstract] [Full Text] [Related]

  • 26. The synthesis and some pharmacological properties of (2-L-DOPA)-oxytocin.
    Ferrier BM, Branda LA.
    Can J Biochem; 1976 May; 54(5):507-11. PubMed ID: 1276975
    [Abstract] [Full Text] [Related]

  • 27. Synthesis and some pharmacological properties of (1-deamino,9-thioglycine)oxytocin.
    Jones WC, Nestor JJ, Du Vigneaud V.
    J Am Chem Soc; 1973 Aug 22; 95(17):5677-9. PubMed ID: 4733810
    [No Abstract] [Full Text] [Related]

  • 28. The deamino derivatives of (4-threonine)-oxytocin and (4-threonine)-mesotocin; analogs possessing a surprising spectrum of diminished pharmacological activities.
    Manning M, Coy EJ, Sawyer WH.
    Experientia; 1971 Aug 22; 27(11):1372-4. PubMed ID: 5167408
    [No Abstract] [Full Text] [Related]

  • 29. Synthesis of oxytocin and related diastereomers deuterated in the half-cystine positions. Comparison of solid-phase and solution methods.
    Spatola AF, Cornelius DA, Hruby VJ, Blomquist AT.
    J Org Chem; 1974 Jul 26; 39(15):2207-12. PubMed ID: 4859518
    [No Abstract] [Full Text] [Related]

  • 30. Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-oxytocin).
    Manning M, Lowbridge J, Sawyer WH, Haldar J.
    J Med Chem; 1976 Mar 26; 19(3):376-80. PubMed ID: 943546
    [Abstract] [Full Text] [Related]

  • 31. Effect of magnesium on the response of the rat mammary gland strip to oxytocin analogues.
    Polácek I, Krejci I.
    Eur J Pharmacol; 1969 Jul 26; 7(1):85-8. PubMed ID: 5387670
    [No Abstract] [Full Text] [Related]

  • 32. Comparison of some biological activities of arginine vasotocin and synthetic analogs.
    Surovec D, Hoffman PL, Walter R.
    Experientia; 1974 Jul 15; 30(7):823-4. PubMed ID: 4847685
    [No Abstract] [Full Text] [Related]

  • 33. Solid phase synthesis of (3,4-dileucine)-oxytocin and a study of some of its pharmacological properties.
    Wille MA, Cahn WY, Du Vigneaud V.
    J Med Chem; 1972 Jan 15; 15(1):11-2. PubMed ID: 5061981
    [No Abstract] [Full Text] [Related]

  • 34. [Letter: Influence of pH on the response of the rat uterus to oxytocin].
    Rovere AA, Saénz GS, Barbero J.
    Acta Physiol Lat Am; 1973 Apr 15; 23(4):317-9. PubMed ID: 4768804
    [No Abstract] [Full Text] [Related]

  • 35. A fraction resembling oxytocin from Squalus acanthias: pharmacological comparisons with synthetic peptides.
    Sawyer WH, Baxter JW, Manning M, Heinicke E, Perks AM.
    Gen Comp Endocrinol; 1970 Aug 15; 15(1):52-8. PubMed ID: 5457017
    [No Abstract] [Full Text] [Related]

  • 36. The effect of decreasing the size of the ring present in deamino-oxytocin by one methylene group on its biological properties. The synthesis of 1-mercaptoacetic acid-oxytocin.
    Jarvis D, Du Vigneaud V.
    J Biol Chem; 1967 Apr 25; 242(8):1768-71. PubMed ID: 6067284
    [No Abstract] [Full Text] [Related]

  • 37. Vasopressin analogues with selective pressor activity.
    Berde B, Boissonnas RA, Huguenin RL, Stürmer E.
    Experientia; 1964 Jan 15; 20(1):42-3. PubMed ID: 5892275
    [No Abstract] [Full Text] [Related]

  • 38. Substrate requirements for the oxytocin-induced motility of isolated rat uterus.
    Goldraij A, Gimeno AL, De Gimeno MF.
    Acta Physiol Lat Am; 1973 Jan 15; 23(2):113-23. PubMed ID: 4795841
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.